Updated By: LatestGKGS Desk
EU & India collaborates for research programme 'Horizon 2020' for Influenza Vaccine
European Union & India collaborates for Research Programme 'Horizon 2020' to develop Next Generation Influenza Vaccine: Details, Significance, Highlights
Union Government and European Union (EU) collaborated for a research programme named ‘Horizon 2020’ to develop Next Generation Influenza Vaccine to protect citizens around the world.
For this research programme 'Horizon 2020', India’s Department of Biotechnology (DBT) and EU committed Euro 15 million (Rs 240 crore). Under this project, a cost-effective and affordable influenza vaccine will be developed.
The influenza vaccine will be developed by EU-India consortia by bringing together multi-disciplinary stakeholders who represent any part of a chain from lab to market. It will comprise a minimum of three applicants from Europe (three different EU member states) or countries associated to EU programme Horizon 2020 and minimum three applicants from India.
It aims at advancing the efficacy, safety, duration of immunity, and reactivity against an increased breadth of influenza strains. Rs. 240 crore fund has been earmarked for research and innovation actions under this project.
The outcome of this project is expected to contribute to the achievement of Sustainable Development Goal 3 (SDG-3) to ensure the health and well-being for all. It will help the international community to better prepare in the event of an influenza pandemic. It will also give boost India’s National Health Mission.
